{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:44795",
      "entity_text" : "ATRA",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05137",
      "entity_text" : "RARalpha fusion gene",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Although we subsequently treated the patient with a combination of arsenic trioxide (ATO) and ATRA, the copy number of the PML / RARalpha fusion gene started to increase 9 weeks after starting ATRA therapy.",
  "reading_complete" : "2020-08-03T15:43:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:42:40Z",
  "trigger" : "increase",
  "evidence" : [ "RARalpha fusion gene started to increase 9 weeks after starting ATRA" ],
  "pmc_id" : "6389481",
  "score" : 0
}